Portfolio Holdings Detail for ISIN IE00BMX0DF60

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam

Holdings detail for AORT

Show aggregate AORT holdings

News associated with AORT

Analysts Set Artivion, Inc. (NYSE:AORT) Target Price at $40.63

Artivion, Inc. (NYSE:AORT – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. […] - 2025-09-12 02:16:54

Comparing Artivion (NYSE:AORT) and Tandem Diabetes Care (NASDAQ:TNDM)

Artivion (NYSE:AORT – Get Free Report) and Tandem Diabetes Care (NASDAQ:TNDM – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, dividends, earnings and risk. Profitability This table compares Artivion and Tandem Diabetes […] - 2025-09-11 02:46:51

Artivion (NYSE:AORT) Rating Lowered to “Hold” at Wall Street Zen

Artivion (NYSE:AORT – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Sunday. Several other analysts also recently weighed in on the company. Citizens Jmp upgraded Artivion to a “strong-buy” rating in a research report on Tuesday, May […] - 2025-08-19 02:50:52

Natixis Advisors LLC Boosts Stock Holdings in Artivion, Inc. (NYSE:AORT)

Natixis Advisors LLC raised its holdings in Artivion, Inc. (NYSE:AORT – Free Report) by 16.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,615 shares of the company’s stock after purchasing an additional 1,777 shares during the period. Natixis Advisors LLC’s […] - 2025-08-13 04:30:57

Artivion (NYSE:AORT) Raised to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Artivion (NYSE:AORT – Free Report) from a hold rating to a buy rating in a report published on Saturday. A number of other brokerages also recently commented on AORT. JMP Securities upped their price objective on shares of Artivion from $33.00 to $42.00 and gave the stock a “market […] - 2025-08-12 02:26:52

Universal Beteiligungs und Servicegesellschaft mbH Invests $3.16 Million in Artivion, Inc. (NYSE:AORT)

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Artivion, Inc. (NYSE:AORT – Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 128,637 shares of the company’s stock, valued at approximately $3,162,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.30% […] - 2025-07-29 05:26:54

New York State Teachers Retirement System Reduces Position in Artivion, Inc. (NYSE:AORT)

New York State Teachers Retirement System decreased its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 4.6% in the first quarter, Holdings Channel.com reports. The institutional investor owned 59,557 shares of the company’s stock after selling 2,900 shares during the quarter. New York State Teachers Retirement System’s holdings in Artivion were worth […] - 2025-07-10 04:50:54

Artivion, Inc. (NYSE:AORT) Given Average Recommendation of “Buy” by Analysts

Shares of Artivion, Inc. (NYSE:AORT – Get Free Report) have been assigned a consensus rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 […] - 2025-06-26 03:10:53

How The Parts Add Up: SPTM Targets $80

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-04 07:53:36

Artivion, Inc. (NYSE:AORT) Receives $31.40 Average PT from Analysts

Artivion, Inc. (NYSE:AORT – Get Free Report) has received an average rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among […] - 2025-06-04 02:12:54

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 24,686 Shares of Artivion, Inc. (NYSE:AORT)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 7.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 316,201 shares of the company’s […] - 2025-06-01 06:08:54

ProShare Advisors LLC Buys 3,683 Shares of Artivion, Inc. (NYSE:AORT)

ProShare Advisors LLC grew its stake in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 44.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,924 shares of the company’s stock after acquiring an additional 3,683 shares during the period. ProShare Advisors LLC’s holdings in Artivion were worth $341,000 at the end of […] - 2025-05-29 05:04:48

Artivion, Inc. (NYSE:AORT) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG increased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 45.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 36,982 shares of the company’s stock after purchasing an additional 11,501 shares during the period. Deutsche Bank AG’s […] - 2025-05-26 04:34:58

BNP Paribas Financial Markets Boosts Stock Position in Artivion, Inc. (NYSE:AORT)

BNP Paribas Financial Markets increased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 9.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,298 shares of the company’s stock after acquiring an additional 2,724 shares during […] - 2025-05-22 04:38:48

Artivion, Inc. (NYSE:AORT) Receives $31.40 Average PT from Brokerages

Shares of Artivion, Inc. (NYSE:AORT – Get Free Report) have been given an average rating of “Buy” by the six ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-05-12 02:54:56

Artivion (NYSE:AORT) Rating Increased to Strong-Buy at Citizens Jmp

Artivion (NYSE:AORT – Get Free Report) was upgraded by equities researchers at Citizens Jmp to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports. Several other equities analysts also recently commented on AORT. Stifel Nicolaus lowered their price objective on shares of Artivion from $33.00 to $30.00 and set a “buy” rating for […] - 2025-05-08 02:44:59

MetLife Investment Management LLC Boosts Stake in Artivion, Inc. (NYSE:AORT)

MetLife Investment Management LLC boosted its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 7.4% in the 4th quarter, Holdings Channel reports. The firm owned 24,103 shares of the company’s stock after purchasing an additional 1,671 shares during the period. MetLife Investment Management LLC’s holdings in Artivion were worth $689,000 at the end of […] - 2025-05-05 05:22:57

Barclays PLC Boosts Stock Holdings in Artivion, Inc. (NYSE:AORT)

Barclays PLC lifted its holdings in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 1.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,697 shares of the company’s stock after buying an additional 820 shares during the quarter. Barclays PLC owned […] - 2025-05-02 06:02:55

Wells Fargo & Company MN Raises Stock Holdings in Artivion, Inc. (NYSE:AORT)

Wells Fargo & Company MN raised its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 22.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 34,823 shares of the company’s stock after purchasing an additional 6,299 shares during the period. Wells Fargo & […] - 2025-04-30 04:41:03

Invesco Ltd. Has $7.64 Million Holdings in Artivion, Inc. (NYSE:AORT)

Invesco Ltd. lifted its position in Artivion, Inc. (NYSE:AORT – Free Report) by 22.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 267,067 shares of the company’s stock after purchasing an additional 49,462 shares during the quarter. Invesco Ltd.’s holdings in […] - 2025-04-25 05:08:54

Bank of Montreal Can Lowers Holdings in Artivion, Inc. (NYSE:AORT)

Bank of Montreal Can lowered its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 29.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,135 shares of the company’s stock after selling 3,455 shares during the period. Bank of […] - 2025-04-25 05:08:49

Analysts Expect 34% Gains Ahead For IJR

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-24 08:25:25

Analyzing Artivion (NYSE:AORT) and Penumbra (NYSE:PEN)

Artivion (NYSE:AORT – Get Free Report) and Penumbra (NYSE:PEN – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Earnings & Valuation This table compares Artivion and Penumbra”s gross […] - 2025-04-23 03:04:50

Legal & General Group Plc Trims Stake in Artivion, Inc. (NYSE:AORT)

Legal & General Group Plc decreased its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 3.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 144,585 shares of the company’s stock after selling 5,621 shares during the quarter. Legal & General […] - 2025-04-22 05:20:50

American Century Companies Inc. Has $1.65 Million Stake in Artivion, Inc. (NYSE:AORT)

American Century Companies Inc. raised its stake in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 57,771 shares of the company’s stock after purchasing an additional 2,764 shares during the quarter. American Century Companies […] - 2025-04-10 04:26:57

KLP Kapitalforvaltning AS Invests $194,000 in Artivion, Inc. (NYSE:AORT)

KLP Kapitalforvaltning AS bought a new stake in Artivion, Inc. (NYSE:AORT – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 6,800 shares of the company’s stock, valued at approximately $194,000. A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AORT. Quarry LP […] - 2025-04-08 05:06:51

Artivion, Inc. (NYSE:AORT) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans cut its holdings in Artivion, Inc. (NYSE:AORT – Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 29,162 shares of the company’s stock after selling 446 shares during the quarter. Thrivent Financial for Lutherans’ holdings […] - 2025-04-03 04:22:46

Intech Investment Management LLC Buys 8,165 Shares of Artivion, Inc. (NYSE:AORT)

Intech Investment Management LLC raised its position in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 77.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 18,695 shares of the company’s stock after purchasing an additional 8,165 shares during the quarter. Intech Investment Management LLC’s holdings in […] - 2025-03-25 06:29:07

Artivion, Inc. (NYSE:AORT) Position Raised by Amundi

Amundi raised its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 174.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 18,288 shares of the company’s stock after buying an additional 11,634 shares during the quarter. Amundi’s holdings in Artivion were worth $553,000 as of its most […] - 2025-03-21 05:59:08

Illinois Municipal Retirement Fund Lowers Stock Holdings in Artivion, Inc. (NYSE:AORT)

Illinois Municipal Retirement Fund lowered its stake in Artivion, Inc. (NYSE:AORT – Free Report) by 13.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,908 shares of the company’s stock after selling 3,076 shares during the period. Illinois Municipal Retirement Fund’s holdings in Artivion […] - 2025-03-05 08:46:57

iShares US Medical Devices UCITS ETF AORT holdings

Date	Number of AORT Shares Held	Base Market Value of AORT Shares	Local Market Value of AORT Shares	Change in AORT Shares Held	Change in AORT Base Value	Current Price per AORT Share Held	Previous Price per AORT Share Held
2025-09-18 (Thursday)	5,088	USD 210,440	USD 210,440	0	USD 7,174	USD 41.3601	USD 39.9501
2025-09-17 (Wednesday)	5,088	USD 203,266	USD 203,266	0	USD 1,985	USD 39.9501	USD 39.5599
2025-09-16 (Tuesday)	5,088	USD 201,281	USD 201,281
2025-09-15 (Monday)	5,088	USD 202,299	USD 202,299
2025-09-12 (Friday)	5,088	USD 207,082	USD 207,082
2025-09-11 (Thursday)	5,088	USD 215,273	USD 215,273
2025-09-10 (Wednesday)	5,088	USD 208,812	USD 208,812
2025-09-09 (Tuesday)	5,088	USD 215,986	USD 215,986

Share Trades of AORT by Blackrock for IE00BMX0DF60

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-06-27	SELL	-84			31.190*		27.30 Profit of 2,294 on sale
2025-06-12	BUY	126			28.740*		27.14
2025-06-10	SELL	-672			29.240*		27.11 Profit of 18,218 on sale
2025-06-09	SELL	-798			29.190*		27.09 Profit of 21,621 on sale
2025-05-30	SELL	-84			29.580*		27.01 Profit of 2,268 on sale
2025-05-19	BUY	42			29.710*		26.84
2025-05-09	SELL	-225			28.910*		26.72 Profit of 6,012 on sale
2025-04-23	SELL	-46			23.780*		26.96 Profit of 1,240 on sale
2025-04-17	SELL	-45			22.930*		27.14 Profit of 1,221 on sale
2025-04-10	BUY	352			23.530*		27.36
2025-04-04	SELL	-88			23.220*		27.57 Profit of 2,426 on sale
2025-04-02	SELL	-88			25.050*		27.60 Profit of 2,429 on sale
2025-03-31	SELL	-132			24.580*		27.67 Profit of 3,653 on sale
2025-03-19	SELL	-42			24.370*		28.02 Profit of 1,177 on sale
2025-02-28	SELL	-84			25.410*		28.77 Profit of 2,417 on sale
2025-02-05	BUY	132			31.700*		28.63
2025-02-04	BUY	176			30.990*		28.57
2025-01-29	SELL	-44			31.220*		28.31 Profit of 1,246 on sale
2025-01-23	SELL	-44			30.620*		28.03 Profit of 1,233 on sale
2025-01-02	SELL	-84			28.080*		28.03 Profit of 2,354 on sale
2024-12-04	BUY	126			29.650*		27.76
2024-12-03	SELL	-42			29.680*		27.69 Profit of 1,163 on sale
2024-12-02	SELL	-504			29.620*		27.61 Profit of 13,918 on sale
2024-11-29	SELL	-840			29.520*		27.54 Profit of 23,132 on sale
2024-11-27	SELL	-126			29.050*		27.41 Profit of 3,453 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AORT

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer